Impact of HPV in Oropharyngeal Cancer
- PMID: 21234307
- PMCID: PMC3018627
- DOI: 10.1155/2011/509036
Impact of HPV in Oropharyngeal Cancer
Abstract
The incidence of oropharyngeal cancers has increased in the western world and Human Papilloma Virus (HPV) has been recognised as a risk factor in the last decades. During the same period the prevalence of HPV in oropharyngeal tumours has increased and HPV has been suggested responsible for the increase. The HPV-positive tumours are today recognized as a distinct subset of head and neck cancers with its own clinopathological and risk profile and have a significantly improved prognosis regardless of treatment strategy. This review summarizes current knowledge regarding human papillomavirus biology, oncogenic mechanisms, risk factors, and impact of treatment.
References
-
- Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Seminars in Oncology. 2004;31(6):744–754. - PubMed
-
- Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. European Journal of Cancer. 2002;38(1):99–166. - PubMed
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca-A Cancer Journal for Clinicians. 2005;55(2):74–108. - PubMed
-
- Pindborg JJ, Zheng KH, Kong CR, Lin FX. Pilot survey of oral mucosa in areca (betel) nut chewers on Hainan Island of the People’s Republic of China. Community Dentistry and Oral Epidemiology. 1984;12(3):195–196. - PubMed
-
- Licitra L, Bernier J, Grandi C, Merlano M, Bruzzi P, Lefebvre JL. Cancer of the oropharynx. Critical Reviews in Oncology/Hematology. 2002;41(1):107–122. - PubMed
LinkOut - more resources
Full Text Sources
